Related references
Note: Only part of the references are listed.Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis
Cristiano A. Kohler et al.
MOLECULAR NEUROBIOLOGY (2018)
Safety and Toxicology of Magnolol and Honokiol
Andrea Sarrica et al.
PLANTA MEDICA (2018)
Calcium-Dependent Desensitization of NMDA Receptors
D. A. Sibarov et al.
BIOCHEMISTRY-MOSCOW (2018)
The Function of the Mitochondrial Calcium Uniporter in Neurodegenerative Disorders
Yajin Liao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents
Melanie Poivre et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2017)
Cancer Chemoprevention by Phytochemicals: Nature's Healing Touch
Haseeb Zubair et al.
MOLECULES (2017)
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases
Michael D. Lovelace et al.
NEUROPHARMACOLOGY (2017)
Honokiol abrogates chronic restraint stress-induced cognitive impairment and depressive-like behaviour by blocking endoplasmic reticulum stress in the hippocampus of mice
Ashok Jangra et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
New in vitro insights on a cell death pathway induced by magnolol and honokiol in aristolochic acid tubulotoxicity
Valerian Bunel et al.
FOOD AND CHEMICAL TOXICOLOGY (2016)
Acute restraint stress induces specific changes in nitric oxide production and inflammatory markers in the rat hippocampus and striatum
Hsiao-Jou Cortina Chen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis
Chien-Ju Lin et al.
PHYTOMEDICINE (2016)
Inflammation and clinical response to treatment in depression: A meta-analysis
R. Strawbridge et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Beneficial effect of honokiol on lipopolysaccharide induced anxiety-like behavior and liver damage in mice
Kunjbihari Sulakhiya et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
Christoph U. Correll et al.
WORLD PSYCHIATRY (2015)
Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems
Anna Gądek-Michalska et al.
Pharmacological Reports (2014)
Network beyond IDO in psychiatric disorders: Revisiting neurodegeneration hypothesis
Aye-Mu Myint et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Jacqueline Quak et al.
PSYCHONEUROENDOCRINOLOGY (2014)
IL-1 and TNF- induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase
Ling Ye et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-κB activation and cytokine production of glial cells
Peng Zhang et al.
NEUROSCIENCE LETTERS (2013)
Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway
Jia-Wei Lin et al.
NEURO-ONCOLOGY (2012)
Depressive-like behavior induced by tumor necrosis factor-alpha in mice
Manuella P. Kaster et al.
NEUROPHARMACOLOGY (2012)
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Jonas Hannestad et al.
NEUROPSYCHOPHARMACOLOGY (2011)
The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
M. Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Inflammation-associated depression: From serotonin to kynurenine
Robert Dantzer et al.
PSYCHONEUROENDOCRINOLOGY (2011)
Magnolol potently suppressed lipopolysaccharide-induced iNOS and COX-2 expression via downregulating MAPK and NF-κB signaling pathways
Ching-Shu Lai et al.
JOURNAL OF FUNCTIONAL FOODS (2011)
Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan-kynurenine metabolism
Gregory F. Oxenkrug
NEUROPROTECTIVE AGENTS (2010)
The pharmacological properties of antidepressants
Giorgio Racagni et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
The possible role of the kynurenine pathway in adolescent depression with melancholic features
Vilma Gabbay et al.
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY (2010)
Honokiol and Magnolol as Multifunctional Antioxidative Molecules for Dermatologic Disorders
Jui-Lung Shen et al.
MOLECULES (2010)
Nuclear factor-κB is a critical mediator of stress-impaired neurogenesis and depressive behavior
Ja Wook Koo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Andrew H. Miller et al.
BIOLOGICAL PSYCHIATRY (2009)
Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guerin
Jason C. O'Connor et al.
JOURNAL OF NEUROSCIENCE (2009)
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
J. C. O'Connor et al.
MOLECULAR PSYCHIATRY (2009)
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression
Michael Maes et al.
METABOLIC BRAIN DISEASE (2009)
Calcium Pumps in Health and Disease
Marisa Brini et al.
PHYSIOLOGICAL REVIEWS (2009)
Indoleamine 2,3-dioxygenase activation and depressive symptoms in patients with coronary artery disease
Walter Swardfager et al.
PSYCHONEUROENDOCRINOLOGY (2009)
Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression
Byung Hun Kim et al.
ACTA PHARMACOLOGICA SINICA (2008)
Honokiol is a potent scavenger of superoxide and peroxyl radicals
Sergey Dikalov et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: Circulating and brain cytokines, plasma corticosterone and behavioral changes in mice
Julie Gibb et al.
BRAIN BEHAVIOR AND IMMUNITY (2008)
LPS/TLR4 signal transduction pathway
Yong-Chen Lu et al.
CYTOKINE (2008)
Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer
Hongyu Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression
I. Goshen et al.
MOLECULAR PSYCHIATRY (2008)
Depression, chronic diseases, and decrements in health: results from the World Health Surveys
Saba Moussavi et al.
LANCET (2007)
Interferon-γ promotes differentiation of neural progenitor cells via the JNK pathway
So Jung Kim et al.
NEUROCHEMICAL RESEARCH (2007)
Twenty years of research on cytokine-induced sickness behavior
Robert Dantzer et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
The proinflammatory cytokines interleukin-1 beta and tumor necrosis factor-alpha activate serotonin transporters
Chong-Bin Zhu et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Cytokine, sickness behavior, and depression
Robert Dantzer
NEUROLOGIC CLINICS (2006)
Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage
Yi-Ruu Lin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Chronic unpredictable stress exacerbates lipopolysaccharide-induced activation of nuclear factor-κB in the frontal cortex and hippocampus via glucocorticoid secretion
CD Munhoz et al.
JOURNAL OF NEUROSCIENCE (2006)
Circuitry of nuclear factor κB signaling
A Hoffmann et al.
IMMUNOLOGICAL REVIEWS (2006)
Cytokines sing the blues: inflammation and the pathogenesis of depression
CL Raison et al.
TRENDS IN IMMUNOLOGY (2006)
Honokiol inhibits TNF-α-stimulated NF-κB activation and NF-κB-regulated gene expression through suppression of IKK activation
AKW Tse et al.
BIOCHEMICAL PHARMACOLOGY (2005)
IDO and interferon-α-induced depressive symptoms:: a shift in hypothesis from tryptophan depletion to neurotoxicity
MC Wichers et al.
MOLECULAR PSYCHIATRY (2005)
In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp.
J Park et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Interferon-γ-induced conversion of tryptophan:: Immunologic and neuropsychiatric aspects
B Wirleitner et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Interferon γ induces retrograde dendritic retraction and inhibits synapse formation
IJ Kim et al.
JOURNAL OF NEUROSCIENCE (2002)
Missing pieces in the NF-κB puzzle
S Ghosh et al.
CELL (2002)
Share Paper
